Stock Analysis
Kancelaria Medius (WSE:KME) Second Quarter 2024 Results
Key Financial Results
- Revenue: zł3.63m (down 2.2% from 2Q 2023).
- Net income: zł264.0k (down 93% from 2Q 2023).
- Profit margin: 7.3% (down from 100% in 2Q 2023). The decrease in margin was primarily driven by higher expenses.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Kancelaria Medius shares are down 13% from a week ago.
Risk Analysis
Before you take the next step you should know about the 4 warning signs for Kancelaria Medius (3 make us uncomfortable!) that we have uncovered.
Valuation is complex, but we're here to simplify it.
Discover if Kancelaria Medius might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About WSE:KME
Kancelaria Medius
Engages in debt portfolios management in Poland, Spain, Mexico, and the Czech Republic.
